Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects
- PMID: 15902557
- DOI: 10.1007/s10545-005-0545-4
Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects
Abstract
We report two infants identified by tandem mass spectrometry (MS/MS) of neonatal blood spot acylcarnitines and confirmed by molecular genetic analysis to have long-chain fatty acid oxidation defects. In both cases, acylcarnitine concentrations in confirmatory plasma samples were normal. None the less, molecular testing identified trifunctional protein (TFP) deficiency (McKusick 600890) and very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency (McKusick 201475).
Similar articles
-
Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.Dis Markers. 2019 Feb 7;2019:2984747. doi: 10.1155/2019/2984747. eCollection 2019. Dis Markers. 2019. PMID: 30881520 Free PMC article.
-
Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPD.Mol Genet Metab. 2020 Sep-Oct;131(1-2):90-97. doi: 10.1016/j.ymgme.2020.09.001. Epub 2020 Sep 6. Mol Genet Metab. 2020. PMID: 32928639 Free PMC article.
-
Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.Mol Genet Metab. 2006 Jan;87(1):40-7. doi: 10.1016/j.ymgme.2005.09.018. Epub 2005 Nov 16. Mol Genet Metab. 2006. PMID: 16297647
-
Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.J Hum Genet. 2019 Feb;64(2):73-85. doi: 10.1038/s10038-018-0527-7. Epub 2018 Nov 6. J Hum Genet. 2019. PMID: 30401918 Review.
-
Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.J Inherit Metab Dis. 2010 Oct;33(5):527-32. doi: 10.1007/s10545-010-9090-x. Epub 2010 May 7. J Inherit Metab Dis. 2010. PMID: 20449660 Review.
Cited by
-
False-positive newborn screening result and future health care use in a state Medicaid cohort.Pediatrics. 2011 Oct;128(4):715-22. doi: 10.1542/peds.2010-2448. Epub 2011 Sep 19. Pediatrics. 2011. PMID: 21930552 Free PMC article.
-
High-resolution melting analysis, a simple and effective method for reliable mutation scanning and frequency studies in the ACADVL gene.J Inherit Metab Dis. 2010 Jun;33(3):247-60. doi: 10.1007/s10545-010-9101-y. Epub 2010 May 18. J Inherit Metab Dis. 2010. PMID: 20480395
-
Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl-coA dehydrogenase (VLCAD) deficiency in the United States.Mol Genet Metab. 2015 Nov;116(3):139-45. doi: 10.1016/j.ymgme.2015.08.011. Epub 2015 Sep 2. Mol Genet Metab. 2015. PMID: 26385305 Free PMC article.
-
A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency.Mol Genet Metab. 2009 Mar;96(3):85-90. doi: 10.1016/j.ymgme.2008.09.008. Epub 2009 Jan 20. Mol Genet Metab. 2009. PMID: 19157942 Free PMC article.
-
Delayed Diagnosis of Glutaric Aciduria Type 1: A Case Report.Cureus. 2025 Jun 19;17(6):e86380. doi: 10.7759/cureus.86380. eCollection 2025 Jun. Cureus. 2025. PMID: 40688972 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous